Cargando…

Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI

Introduction. Many patients with mild/moderate traumatic brain injury (m/mTBI) in the chronic stage suffer from executive brain function impairment. Analyzing brain metabolism is important for elucidating the pathological mechanisms associated with their symptoms. This study aimed to determine the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Keiichi, Asano, Yoshitaka, Ikegame, Yuka, Shinoda, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977387/
https://www.ncbi.nlm.nih.gov/pubmed/27529067
http://dx.doi.org/10.1155/2016/3794029
_version_ 1782447018440916992
author Ito, Keiichi
Asano, Yoshitaka
Ikegame, Yuka
Shinoda, Jun
author_facet Ito, Keiichi
Asano, Yoshitaka
Ikegame, Yuka
Shinoda, Jun
author_sort Ito, Keiichi
collection PubMed
description Introduction. Many patients with mild/moderate traumatic brain injury (m/mTBI) in the chronic stage suffer from executive brain function impairment. Analyzing brain metabolism is important for elucidating the pathological mechanisms associated with their symptoms. This study aimed to determine the differences in brain glucose metabolism between m/mTBI patients with and without visible traumatic brain lesions based on MRI. Methods. Ninety patients with chronic m/mTBI due to traffic accidents were enrolled and divided into two groups based on their MRI findings. Group A comprised 50 patients with visible lesions. Group B comprised 40 patients without visible lesions. Patients underwent FDG-PET scans following cognitive tests. FDG-PET images were analyzed using voxel-by-voxel univariate statistical tests. Results. There were no significant differences in the cognitive tests between Group A and Group B. Based on FDG-PET findings, brain metabolism significantly decreased in the orbital gyrus, cingulate gyrus, and medial thalamus but increased in the parietal and occipital convexity in Group A compared with that in the control. Compared with the control, patients in Group B exhibited no significant changes. Conclusions. These results suggest that different pathological mechanisms may underlie cognitive impairment in m/mTBI patients with and without organic brain damage.
format Online
Article
Text
id pubmed-4977387
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49773872016-08-15 Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI Ito, Keiichi Asano, Yoshitaka Ikegame, Yuka Shinoda, Jun Biomed Res Int Research Article Introduction. Many patients with mild/moderate traumatic brain injury (m/mTBI) in the chronic stage suffer from executive brain function impairment. Analyzing brain metabolism is important for elucidating the pathological mechanisms associated with their symptoms. This study aimed to determine the differences in brain glucose metabolism between m/mTBI patients with and without visible traumatic brain lesions based on MRI. Methods. Ninety patients with chronic m/mTBI due to traffic accidents were enrolled and divided into two groups based on their MRI findings. Group A comprised 50 patients with visible lesions. Group B comprised 40 patients without visible lesions. Patients underwent FDG-PET scans following cognitive tests. FDG-PET images were analyzed using voxel-by-voxel univariate statistical tests. Results. There were no significant differences in the cognitive tests between Group A and Group B. Based on FDG-PET findings, brain metabolism significantly decreased in the orbital gyrus, cingulate gyrus, and medial thalamus but increased in the parietal and occipital convexity in Group A compared with that in the control. Compared with the control, patients in Group B exhibited no significant changes. Conclusions. These results suggest that different pathological mechanisms may underlie cognitive impairment in m/mTBI patients with and without organic brain damage. Hindawi Publishing Corporation 2016 2016-07-26 /pmc/articles/PMC4977387/ /pubmed/27529067 http://dx.doi.org/10.1155/2016/3794029 Text en Copyright © 2016 Keiichi Ito et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ito, Keiichi
Asano, Yoshitaka
Ikegame, Yuka
Shinoda, Jun
Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI
title Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI
title_full Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI
title_fullStr Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI
title_full_unstemmed Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI
title_short Differences in Brain Metabolic Impairment between Chronic Mild/Moderate TBI Patients with and without Visible Brain Lesions Based on MRI
title_sort differences in brain metabolic impairment between chronic mild/moderate tbi patients with and without visible brain lesions based on mri
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977387/
https://www.ncbi.nlm.nih.gov/pubmed/27529067
http://dx.doi.org/10.1155/2016/3794029
work_keys_str_mv AT itokeiichi differencesinbrainmetabolicimpairmentbetweenchronicmildmoderatetbipatientswithandwithoutvisiblebrainlesionsbasedonmri
AT asanoyoshitaka differencesinbrainmetabolicimpairmentbetweenchronicmildmoderatetbipatientswithandwithoutvisiblebrainlesionsbasedonmri
AT ikegameyuka differencesinbrainmetabolicimpairmentbetweenchronicmildmoderatetbipatientswithandwithoutvisiblebrainlesionsbasedonmri
AT shinodajun differencesinbrainmetabolicimpairmentbetweenchronicmildmoderatetbipatientswithandwithoutvisiblebrainlesionsbasedonmri